Article
Development of a novel mechanism-based glycolipid adjuvant for vaccination
2018-05-30
Abstract excerpt
The inability to elicit strong and durable cellular responses is a major obstacle in the development of successful vaccines, in particular those against malaria. In this regard, the generation of novel adjuvants that will potently boost cell-mediated immunity induced by candidate vaccines is helpful. We and others have found a glycolipid, called α-galactosylceramide (α-GalCer), which could be presented on CD1d exp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7b7cdd17-065f-5293-811b-e244faebc2a4
- DOI
- 10.12688/f1000research.13794.1
